Anesthesiology · 2013 · 17 citations · 31 references
Life SciencesCardiologyGeneticsCellular MetabolismMitochondrial BiologyMitochondrial GeneticsMitochondrial BiochemistryMitochondrial DysfunctionMitochondrial MetabolismMitochondrial PhysiologyMitochondrial Redox BiologyMitochondrial SignalingCardiac Mitochondrial FunctionInfarct Size AssessmentMitochondrial Dna Oxidative DamageMitochondrial Function In CardiomyocytesMitochondrial Oxidative StressMitochondrial Redox StateMyocardial Ischemia-reperfusion InjuryReactive Oxygen Species Generation
BACKGROUND: Diabetes alters mitochondrial bioenergetics and consequently disrupts cardioprotective signaling. The authors investigated whether mitochondrial DNA (mtDNA) modulates anesthetic preconditioning (APC) and cardiac susceptibility to ischemia-reperfusion injury by using two strains of rats, both sharing nuclear genome of type 2 diabetes mellitus (T2DN) rats and having distinct mitochondrial genomes of Wistar and fawn-hooded hypertensive (FHH) rat strains (T2DN(mtWistar) and T2DN(mtFHH), respectively). METHODS: Myocardial infarct size was measured in Wistar, T2DN(mtWistar), and T2DN(mtFHH) rats with or without APC (1.4% isoflurane) in the presence or absence of antioxidant N-acetylcysteine. Flavoprotein fluorescence intensity, a marker of mitochondrial redox state, 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity, a marker of reactive oxygen species generation, and mitochondrial permeability transition pore opening were assessed in isolated rat ventricular cardiomyocytes with or without isoflurane (0.5 mmol/l). RESULTS: Myocardial infarct size was decreased by APC in Wistar and T2DN(mtWistar) rats (to 42 ± 6%, n = 8; and 44 ± 7%, n = 8; of risk area, respectively) compared with their respective controls (60 ± 3%, n = 6; and 59 ± 9%, n = 7), but not in T2DN(mtFHH) rats (60 ± 2%, n = 8). N-acetylcysteine applied during isoflurane treatment restored APC in T2DN(mtFHH) (39 ± 6%, n = 7; and 38 ± 5%, n = 7; 150 and 75 mg/kg N-acetylcysteine, respectively), but abolished protection in control rats (54 ± 8%, n = 6). Similar to the data on infarct size, APC delayed mitochondrial permeability transition pore opening in T2DN(mtWistar) but not in T2DN(mtFHH) cardiomyocytes. Isoflurane increased flavoprotein and 5-(and-6)-chloromethyl-2',7'-dichlorofluorescein fluorescence intensity in all rat strains, with the greatest effect in T2DN(mtFHH) cardiomyocytes. CONCLUSION: Differences in the mitochondrial genome modulate isoflurane-induced generation of reactive oxygen species which translates into differential susceptibility to APC and ischemia-reperfusion injury in diabetic rats.
31
Mitochondrial Dysfunction and Type 2 Diabetes
Bradford B. Lowell, Gerald I. Shulman · Science · 2005 · 2.1K citations
Reactive Oxygen Species (Ros-Induced) Ros Release
Dmitry B. Zorov, Charles R. Filburn, Lars‐Oliver Klotz et al. · The Journal of Experimental Medicine · 2000 · 1.4K citations · Full text
Mortality and causes of death in the WHO multinational study of vascular disease in diabetes
N. J. Morrish, S.-L. Wang, Lynda Stevens et al. · Diabetologia · 2001 · 1.3K citations · Full text
Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
Sihem Boudina, Sandra Sena, Heather Theobald et al. · Diabetes · 2007 · 586 citations · Full text
Isoflurane Mimics Ischemic Preconditioning via Activation of KATPChannels
Judy R. Kersten, Todd J. Schmeling, Paul S. Pagel et al. · Anesthesiology · 1997 · 423 citations · Full text
Medicine, Cardiology, Pharmacology +12